Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Austria Health Focus.
Phytochemical Market Set to Reach USD 55.66 Billion, with a Healthy 3.6% CAGR Till Forecasts 2034
EIN Presswire
·
March 20, 2025
The phytochemical market has a bright future with more and more consumers being aware of their health and wellbeing. NEW YORK , NY, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- The global phytochemical market is experiencing significant...
Sunday Health and Re:Cognition Health Form Collaboration to Transform Cognitive Care and Delay Dementia
EIN Presswire
·
March 10, 2025
ALEXANDRIA, VA, UNITED STATES, March 10, 2025 /EINPresswire.com/ -- Sunday Health, Inc., a provider of personalized cognitive care, and Re:Cognition Health, a leader in clinical trials and FDA-approved treatments for Alzheimer’s and related...
Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
GlobeNewswire, Inc.
·
March 21, 2025
Philadelphia, PA, March 21, 2025 (GLOBE NEWSWIRE) -- Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., in collaboration with scientists in the laboratory of Norbert Pardi, Ph.D., at the University of Pennsylvania Perelman School of...
CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
GlobeNewswire, Inc.
·
March 10, 2025
A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; p=0.003 vs. placebo) on the primary outcome measure, change from baseline in Clinical Dementia Rating Sum of...
Acumen Pharmaceuticals to Present During International Conference on Alzheimer’s and Parkinson’s Diseases 2025 and American Academy of Neurology Annual Meeting
GlobeNewswire, Inc.
·
March 12, 2025
NEWTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of...
Proxygen and EPFL Launch Strategic Collaboration to Advance AI-Driven Glue Discovery
GlobeNewswire, Inc.
·
August 26, 2025
VIENNA and LAUSANNE, Switzerland, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Proxygen, a global leader in the discovery and development of molecular glue degraders, today announced a strategic research collaboration with EPFL (the Swiss Federal Institute...
Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients
GlobeNewswire, Inc.
·
September 8, 2025
Enables biopharmaceutical companies to accelerate precision drug development by delivering real-time patient insights from a global laboratory network on track to diagnose 8 million pathology cases annually. Opens new streams of revenue for...
Dream's Documentary Featured in Economy 4.0 Series hosted on CBS News - Building AI Cyber Defense for Nations
EIN Presswire
·
September 5, 2025
TEL AVIV, ISRAEL, September 5, 2025 /EINPresswire.com/ -- Governments are under attack. Hospitals can be paralyzed, power grids shut down, and ministries hacked. Nation-state adversaries are exploiting vulnerabilities at unprecedented scale,...
LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight
GlobeNewswire, Inc.
·
March 3, 2025
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of...
Amarin Receives National Reimbursement for VAZKEPA® in Austria
GlobeNewswire, Inc.
·
February 25, 2025
-- Austrian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Risk of Cardiovascular Events in Eligible Patients -- -- Effective 1 April 2025, Austrian Reimbursement Marks 10th National Reimbursement for...
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
GlobeNewswire, Inc.
·
March 4, 2025
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in...
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025
GlobeNewswire, Inc.
·
February 26, 2025
NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in AI-driven ultrasound cancer diagnosis, today announced...
The Sequoia Project Announces Detailed Agenda of Virtual Data Usability Workshop, Co-Sponsored by AHIMA
GlobeNewswire, Inc.
·
August 25, 2025
VIENNA, Va., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Sequoia Project, a non-profit and trusted advocate for nationwide health IT interoperability, in partnership with the American Health Information Management Association (AHIMA), is releasing the...
Nanox to Present New Clinical Data on Nanox.ARC Advanced 3D Digital Tomosynthesis Imaging System at ECR 2025
GlobeNewswire, Inc.
·
February 25, 2025
In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition, can improve cast and metal imaging, eliminate the...
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
GlobeNewswire, Inc.
·
February 22, 2025
New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different doses New endpoints presented include findings on clinical and endoscopic outcomes and histological-...
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
GlobeNewswire, Inc.
·
February 22, 2025
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the...
Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures February 2025
International Committee of the Red Cross
·
March 2, 2025
The Red Cross Field Hospital was established and opened on 9 May 2024, and is implemented in coordination with the Palestine Red Crescent Society and supported by Red Cross Societies of Australia, Austria, Canada, China (Hong Kong branch),...
Multilateral action for a healthy planet and people
UN Environmental Program
·
March 4, 2025
Check against delivery Excellencies, Thank you for the opportunity to speak to you today about UNEP’s work and key upcoming moments to strengthen multilateral action on the environment. Even amid a complex geopolitical context, the need for such...
FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication
U.S. Food and Drug Administration
·
August 25, 2025
AUDIENCE: Patient, Health Care Professional, Pharmacy, Cardiology, Neurology, Internal Medicine, Family Practice, Travel Clinics UPDATE: On August 22, 2025, the US FDA’s Center for Biologics Evaluation and Research (CBER) has suspended the...
Healthy Meal Delivery Services Market to Witness Stunning Growth with Green Chef, Veestro, Factor75
EIN Presswire
·
November 8, 2024
Stay up-to-date with Healthy Meal Delivery Services Market Research offered by HTF MI.Check how key trends and emerging drivers are shaping this industry growth PUNE, MAHARASHTRA, INDIA, November 8, 2024 /EINPresswire.com/ -- The Global Healthy...